Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial

机译：糠酸莫米松和富马酸福莫特罗固定剂量组合对中度至非常重度COPD患者的疗效和安全性：一项为期52周的III期临床试验的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundA clinical trial of mometasone furoate/formoterol fumarate (MF/F) administered via a metered-dose inhaler in subjects with moderate to very severe chronic obstructive pulmonary disease (COPD) investigated the efficacy and safety of a fixed-dose combination of MF/F.

机译：背景一项通过计量吸入器给药的糠酸莫米他松/富马酸福莫特罗（MF / F）在中度至重度慢性阻塞性肺疾病（COPD）受试者中的临床试验研究了MF / F固定剂量联合用药的有效性和安全性。

著录项

期刊名称 International Journal of Chronic Obstructive Pulmonary Disease
作者
Donald P Tashkin; Dennis E Doherty; Edward Kerwin; Carlos E Matiz-Bueno; Barbara Knorr; Tulin Shekar; Sibabrata Banerjee; Heribert Staudinger;
展开▼
作者单位

展开▼
年(卷),期 2012(7),-1
年度 2012
页码 43–55
总页数 13
原文格式 PDF
正文语种
中图分类呼吸生理学;
关键词
chronic obstructive pulmonary disease FEV1 spirometry exacerbation inhaled corticosteroid bronchodilator;

机译：慢性阻塞性肺疾病;FEV1;肺活量测定;病情加重;吸入糖皮质激素;支气管扩张药;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial [J] . Donald P Tashkin, Dennis E Doherty, Edward Kerwin, International Journal of Chronic Obstructive Pulmonary Disease . 2012,第1期

机译：糠酸莫米松和富马酸福莫特罗固定剂量联合用药对中度至非常重度COPD患者的疗效和安全性：一项为期52周的III期临床试验的结果
2. Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD [J] . Dennis E Doherty, Donald P Tashkin, Edward Kerwin, International Journal of Chronic Obstructive Pulmonary Disease . 2012,第3期

机译：糠酸莫米他松/富马酸福莫特罗固定剂量联合制剂对慢性阻塞性肺疾病（COPD）的影响：一项为期52周的中度至非常重度COPD受试者的III期试验结果
3. Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials [J] . Donald P Tashkin, Dennis E Doherty, Edward Kerwin, International Journal of Chronic Obstructive Pulmonary Disease . 2012,第1期

机译：糠酸莫米松/富马酸福莫特罗固定剂量联合用药在中度至重度COPD患者中的疗效和安全性：两项随机，52周安慰剂对照试验的合并分析结果
4. Efficacy and Safety of Combination of Prescription Omega-3 (Omacor~R) Added to Stable Statin Therapy in Hypertriglyceridemic Subjects: The COMBOS Trial [C] . M.H. Davidson, H. Bays, E.A. Stein, International Congress on Coronary Artery Disease . 2007

机译：处方ω-3（Omacor〜R）组合的疗效和安全性在高钙化血症科目中添加到稳定的汀类药物治疗：Combos试验
5. Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD [O] . Dennis E Doherty, Donald P Tashkin, Edward Kerwin, 2012

机译：糠酸莫米松/富马酸福莫特罗固定剂量联合制剂对慢性阻塞性肺疾病（COPD）的影响：一项为期52周的中度至非常重度COPD受试者的III期试验结果
6. Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial [O] . Tashkin, Donald P, Doherty, Dennis E, Kerwin, Edward, 2012

机译：糠酸莫米松和富马酸福莫特罗固定剂量联合用药对中度至重度COPD患者的疗效和安全性：一项为期52周的III期临床试验的结果

Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅